MUC1 and cancer: The overexpression (>10-fold) of MUC1 is often associated with a variety of malignant tumors, including breast, gastric, colorectal, lung, prostate, ovarian, pancreatic, and bladder carcinomas4, making MUC1 an ideal target molecule for tumor labeling and chemotherapeutics.